Society features

Infectious Diseases Society of America Foundation Launches 2022 “IDea” Incubator Competition

Newswise – Arlington, Virginia – June 17, 2022 — The Infectious Diseases Society of America Foundation has launched the IDea 2022 Incubator, the first infectious disease technology showcase. This pitch-style competition stimulates innovations in various disciplines with the potential to improve infectious disease specialty and patient care. Winning entries can receive up to $10,000 in funding.

The IDea Incubator competition encourages innovators and start-ups with original inventions, products and ideas that have the potential to improve infectious disease care to share their ideas with the ID community. Finalists are invited to pitch to the ID community in a pitch competition and receive feedback from a panel of judges and experts in medicine, technology and business during IDENTIFIERThe week. Winners receive up to $10,000 in funding.

Applications will be accepted until August 4. Applicants and finalists will be notified the week of August 22, and final winners will be honored during the live pitch competition during IDENTIFIERWeek in Washington, D.C. To apply or learn more about contest rules, please visit www.idsafoundation.org/ideaincubator.

“The burden of infectious disease has become increasingly apparent over the last few years of the pandemic,” said Javeed Siddiqui, MD, MPH, founder and chief medical officer of TeleMed2U. “We are proud to recognize and encourage innovators who are making breakthrough advances to fight all infectious diseases and improve patient care. »

Dr. Siddiqui launched the first IDea incubator in IDENTIFIERWeek in 2018. Since then, the competition has awarded nearly $70,000 in funding.

The grand prize winners of the IDea Incubator 2021 competition were Sanjay Jain, MD, Filipa Mota, PhD, and Alvaro Ordonez, MD, of Johns Hopkins University for their innovation, molecular imaging of bacterial infections. The team developed F-FDS, a patent-pending bacteria-specific PET imaging technology that differentiates Gram-negative bacterial infections from other diseases, such as cancer metastases and tumors. Unlike more traditional approaches to diagnosing infections, F-FDS requires no surgery or biopsy, has nearly 100% specificity, and can detect infections anywhere in the body with rapid results available the same day.

###

About the IDSA Foundation

Founded in 2001, the IDSA Foundation is the charitable arm of the Infectious Diseases Society of America. The Foundation is committed to providing career development opportunities, supporting education and funding innovative research in the field of infectious diseases. Through its work, the Foundation invests in the next generation of diverse identification leaders and promotes advancements in patient care. For more information, visit idsafoundation.org.

About IDWeek

IDENTIFIERThe week is the annual meeting of the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, Pediatric Infectious Diseases Society, and Society of Infectious Diseases Pharmacists. IDENTIFIERThe week features the latest scientific and bench-to-bedside approaches to the prevention, diagnosis, treatment and epidemiology of infectious diseases, including HIV, across the lifespan. IDENTIFIERWeek 2022 will take place October 19-23 in Washington, D.C. For more information, visit www.idweek.org.